Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 37.5%

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 9,900 shares, a growth of 37.5% from the January 31st total of 7,200 shares. Based on an average trading volume of 837,800 shares, the days-to-cover ratio is currently 0.0 days. Approximately 2.3% of the company’s shares are sold short.

Avalon GloboCare Trading Up 18.6 %

ALBT stock opened at $10.69 on Wednesday. Avalon GloboCare has a 12 month low of $2.11 and a 12 month high of $21.60. The stock has a market cap of $11.69 million, a PE ratio of -0.54 and a beta of 0.19. The company has a 50-day moving average price of $4.22 and a 200 day moving average price of $3.73.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.